The Nature and Significance of Platelet Products in Human Plasma
1967/05/01 by Peter Wolf · 34 citations
Medicine · #Blood properties and coagulation #Genital Health and Disease #Platelet Disorders and Treatments
paper · doi:10.1111/j.1365-2141.1967.tb08741.x
Abstract
SUMMARY Fresh plasma freed of intact platelets can be shown to contain minute particulate material (platelet‐dust) which can be separated by ultracentrifugation. Much of this material is rich in phospholipid and shows coagulant properties resembling those of Platelet Factor 3. The supernatant plasma, freed of these particles, shows a corresponding deficiency in Platelet Factor 3 activity. Electron microscopic studies suggest that the lipid‐rich particles may originate from the osmophilic granules of platelets and that they are extruded on storage of platelets, even in the absence of coagulation. It is suggested that the liberation of this material is the basis of the process of ‘activation’ of platelets known to occur with storage. When clotting occurs, coagulant particulate material is released from platelets, considerably in excess of what is required for thrombin generation and it can be detected in serum. Its presence accounts for the platelet‐like activity of serum. The material can be distinguished from intact platelets, red cell stroma and chylomicra. It was observed that chylomicra, freed of platelet‐dust, were inactive in a thrombin generation test, which thus appeared responsive only to platelet type lipid. Both chylomicra and platelet‐dust were effective in a Stypven time test. Attention is drawn to possible errors of interpretation which may arise from the use of the latter test as an index of Platelet Factor 3 activity. Preliminary immunological investigation of platelets revealed the presence of fibrinogen and at least three other constitutents which appear to be primarily platelet components.
Cited by
- Exosomes
- Mechanisms of microRNA Export in Mammalian Cells: From Random Release to Selective Secretion
- Extracellular vesicles as personalized medicine
- The role of neutrophils in thrombosis
- Significance of Extracellular Vesicles: Pathobiological Roles in Disease
- Exosomes: Isolation, characterization, and biomedical applications
- Microscopic messengers: Extracellular vesicles shaping gastrointestinal health and disease
- Autophagy–exosome crosstalk in neurodegeneration: Mechanisms and therapeutic opportunities
- DNA nanotechnology-enabled bioanalysis of extracellular vesicles
- Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. [europepmc]
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. [europepmc]
- Microparticles in hemostasis and thrombosis. [europepmc]
- Intercellular transport of microRNAs. [europepmc]
- Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. [europepmc]
- Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. [europepmc]
- Current knowledge on exosome biogenesis and release. [europepmc]
- Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery. [europepmc]
- Ultrafiltration combined with size exclusion chromatography efficiently isolates extracellular vesicles from cell culture media for compositional and functional studies. [europepmc]
- Exosome-Based Cell-Cell Communication in the Tumor Microenvironment. [europepmc]
- The Platelet Lifeline to Cancer: Challenges and Opportunities. [europepmc]
- Molecular interactions at the surface of extracellular vesicles. [europepmc]
- Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression. [europepmc]
- Exosomes in cancer development and clinical applications. [europepmc]
- Extracellular membrane vesicles in the three domains of life and beyond. [europepmc]
- Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. [europepmc]
- Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. [europepmc]
- Advances in therapeutic applications of extracellular vesicles. [europepmc]
- Extracellular vesicles or exosomes? On primacy, precision, and popularity influencing a choice of nomenclature. [europepmc]
- Shedding Light on Extracellular Vesicle Biogenesis and Bioengineering. [europepmc]
- The power of imaging to understand extracellular vesicle biology in vivo. [europepmc]
- Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. [europepmc]
- Exosomes─Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. [europepmc]
- Engineered exosomes from different sources for cancer-targeted therapy. [europepmc]
- Liquid biopsy in cancer current: status, challenges and future prospects. [europepmc]
Related